David L Porter Selected Research

CTL019 chimeric antigen receptor

12/2018	Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas.
4/2013	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David L Porter Research Topics

Disease

44	Neoplasms (Cancer) 01/2022 - 01/2002
18	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2002
18	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020 - 04/2013
16	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2022 - 08/2011
16	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2022 - 12/2011
14	Leukemia 12/2017 - 01/2002
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2022 - 01/2003
12	Cytokine Release Syndrome 11/2020 - 04/2013
11	Lymphoma (Lymphomas) 01/2022 - 09/2005
9	Infections 12/2022 - 01/2004
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 05/2006
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 06/2003
4	Bronchiolitis Obliterans Syndrome 01/2018 - 10/2012
3	Critical Illness (Critically Ill) 10/2020 - 01/2016
3	Body Weight (Weight, Body) 10/2014 - 08/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2009 - 02/2006
2	Pain (Aches) 10/2022 - 01/2021
2	Multiple Myeloma 06/2022 - 01/2016
2	Mucositis 06/2022 - 01/2021
2	Liver Diseases (Liver Disease) 01/2019 - 01/2018
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2018 - 12/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018 - 12/2017
2	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 02/2008
2	Liver Failure 01/2018 - 01/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2017 - 01/2016
2	Cytopenia 08/2014 - 08/2013
2	Lymphopenia (Lymphocytopenia) 08/2011 - 11/2005
2	Tumor Lysis Syndrome 08/2011 - 05/2006
2	Myeloid Leukemia (Leukemia, Myelocytic) 08/2009 - 05/2006
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2005 - 11/2002
1	Febrile Neutropenia 12/2022
1	Viremia 10/2022
1	Hemorrhagic Cystitis 10/2022
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 10/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Vitamin D Deficiency 01/2022
1	Macrophage Activation Syndrome 11/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2020
1	cell-associated neurotoxicity 11/2020
1	Disseminated Intravascular Coagulation 11/2020
1	Capillary Leak Syndrome 11/2020
1	Sepsis (Septicemia) 10/2020
1	Venous Thromboembolism 01/2020
1	COVID-19 01/2020
1	Communicable Diseases (Infectious Diseases) 03/2019
1	Hypersensitivity (Allergy) 03/2019

Drug/Important Bio-Agent (IBA)

41	Chimeric Antigen ReceptorsIBA 11/2022 - 08/2011
10	tisagenlecleucelIBA 01/2022 - 04/2013
7	AntigensIBA 12/2018 - 01/2006
5	CytokinesIBA 11/2020 - 09/2003
4	Methotrexate (Mexate)FDA LinkGeneric 06/2022 - 07/2013
4	tocilizumab (atlizumab)FDA Link 01/2020 - 04/2013
4	Pharmaceutical PreparationsIBA 11/2019 - 08/2002
4	Maraviroc FDA Link 03/2019 - 07/2015
3	ibrutinibIBA 11/2022 - 02/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 08/2015
3	Tacrolimus (Prograf)FDA LinkGeneric 03/2019 - 07/2013
2	venetoclaxIBA 12/2022 - 01/2022
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2022 - 01/2002
2	Busulfan (Busulfex)FDA Link 01/2022 - 07/2013
2	fludarabineIBA 01/2022 - 07/2013
2	SteroidsIBA 01/2022 - 01/2019
2	Etanercept (Enbrel)FDA Link 01/2022 - 04/2013
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 01/2002
2	trans-crotonin (CTN)IBA 01/2021 - 03/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2011
2	Biological ProductsIBA 10/2020 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2016
2	Bortezomib (Velcade)FDA Link 03/2019 - 08/2014
2	CTL019 chimeric antigen receptorIBA 12/2018 - 04/2013
2	Thomsen-Friedenreich antibodiesIBA 12/2017 - 06/2011
2	AntibodiesIBA 01/2016 - 06/2011
2	Monoclonal AntibodiesIBA 01/2014 - 06/2003
1	Azacitidine (5 Azacytidine)FDA Link 12/2022
1	CPX-351IBA 12/2022
1	Polysaccharides (Glycans)IBA 10/2022
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 10/2022
1	Heparin (Liquaemin)FDA LinkGeneric 10/2022
1	Basiliximab FDA Link 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2021
1	AntithrombinsIBA 01/2020
1	pegaspargase (Oncaspar)FDA Link 01/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2019

Therapy/Procedure

36	Therapeutics 12/2022 - 01/2002
19	Immunotherapy 01/2022 - 01/2006
19	Stem Cell Transplantation 12/2020 - 01/2002
17	Cell Transplantation 01/2022 - 09/2003
15	Hematopoietic Stem Cell Transplantation 01/2018 - 07/2006
14	Transplantation 11/2019 - 09/2008
13	Drug Therapy (Chemotherapy) 10/2020 - 01/2002
3	Homologous Transplantation 01/2021 - 06/2010
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 04/2014
3	Induction Chemotherapy 08/2013 - 02/2006
2	Length of Stay 06/2022 - 01/2021
2	Organ Transplantation 01/2018 - 10/2005
2	Radiotherapy 01/2013 - 02/2008
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2002 - 01/2002
1	Salvage Therapy 01/2022
1	Nutritional Support (Artificial Feeding) 01/2021